Mitsubishi Chemical picks Bain as preferred bidder for pharma unit, sources say
Japan's Mitsubishi Chemical Group has picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical ...
Mitsubishi Chemical has given Bain first refusal right to negotiate purchase of subsidiary, Nikkei says
Mitsubishi Chemical Group has given the U.S. investment fund Bain Capital the right of first refusal to negotiate the ...
Bain Capital Reportedly In Talks To Buy Mitsubishi Chemical's Pharma Unit For $3.2 Bln
Investment firm Bain Capital is in talks to acquire Mitsubishi Tanabe Pharma Corp., affiliated to Japan's Mitsubishi Chemical Group ...
Wall Street Journal14d
Bain Capital in Talks to Buy Mitsubishi Tanabe Pharma
The U.S. investment company is in the final stages of negotiations to buy the subsidiary, Mitsubishi Tanabe Pharma, for possibly more than 500 billion yen, equivalent to $3.21 billion, the person ...
RS-NEWS14d
Mitsubishi Chemical Eyes $3.2 Billion Deal with Bain Capital
Mitsubishi Chemical Group is stepping up its efforts to streamline operations by entering negotiations with U.S. investment fund Bain Capital to sell its pharmaceutical arm, Mitsubishi Tanabe Pharma.
Health Care Up on GLP-1 Alzheimer's Data -- Health Care Roundup
Health-care companies rose after more promising data for the best-selling Glucagon-like Peptide inhibitor drugs. Shares of Novo Nordisk and Eli Lilly, the two leading producers of GLP-1 drugs, rallied ...
Nasdaq13d
Bain Capital Reportedly In Talks To Buy Mitsubishi Chemical's Pharma Unit For $3.2 Bln
(RTTNews) - Investment firm Bain Capital is in talks to acquire Mitsubishi Tanabe Pharma Corp., affiliated to Japan's Mitsubishi Chemical Group (MTLHF.PK), in a potential deal, reports said citing ...